Boceprevir D9
| Product Name | Boceprevir D9 |
|---|---|
| Alternate Names | Boceprevir Stable Isotopes, Stable Isotopes of Boceprevir |
| CAT No. | CS-O-01469 |
| CAS No. | 1256751-11-7 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 528.73 g/mol |
| Mol. For. | C₂₇H₃₆D₉N₅O₅ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Boceprevir |
| Purity | 95% |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O=C([C@@H](N(C1)C([C@H](C(C)(C)C)NC(NC(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)=O)[C@@H]2[C@H]1C2(C)C)NC(C(C(N)=O)=O)CC3CCC3 |
| Canonical Smiles | CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C |
| InchIKey | LHHCSNFAOIFYRV-BHJZPCNUSA-N |
| Inchl | InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1/i4D3,5D3,6D3 |
| IUPAC | (1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]carbamoylamino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Boceprevir D9 is a deuterated form of Boceprevir, which is a prescription medication used to treat chronic hepatitis C infections in adults. This medication works by inhibiting the hepatitis C virus (HCV) protease enzyme, which is responsible for viral replication in the liver. Boceprevir D9 is used in combination with other antiviral medications such as peginterferon alfa and ribavirin to increase the effectiveness of the treatment.
The deuterated form of Boceprevir, Boceprevir D9, is chemically identical to Boceprevir but contains deuterium atoms instead of hydrogen atoms. This modification results in a slower metabolism of the drug in the body, leading to a longer half-life and increased stability. This makes it a useful tool in pharmacokinetic studies as it can be used to trace the drug in the body.
The recommended dosage of Boceprevir D9 is 800 mg three times a day, taken with food. The medication is available in the form of capsules and should be taken as prescribed by a physician. Boceprevir D9 may cause side effects such as fatigue, nausea, and headache, and it is important to inform a healthcare provider if any of these side effects persist or worsen.
In conclusion, Boceprevir D9 is a deuterated form of Boceprevir used to treat chronic hepatitis C infections in adults. It works by inhibiting the HCV protease enzyme, and it is used in combination with other antiviral medications. Boceprevir D9 has a longer half-life and increased stability due to its deuterated form, making it useful in pharmacokinetic studies. It should be taken as prescribed by a physician and may cause side effects, which should be monitored closely.
Get an Instant Quote
This page contains information about Boceprevir D9. You can buy Boceprevir D9 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Boceprevir D9